Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Ready to see the light on weight loss
GLP-1 agonists, widely used to treat type 2 diabetes and manage obesity, were associated with a lower risk of metastatic progression of certain obesity-related cancers, in particular lung, breast, colorectal and liver cancer, according to study results presented at a media briefing in advance of the upcoming American Society of Clinical Oncology Annual Meeting (ASCO 2026)
Summary GLP-1 weight loss injections are generally safe for appropriate candidates when prescribed and monitored by a healthcare provider
Regular appointments to track your progress and make any necessary adjustments
Education is provided so patients understand how therapy works and what to expect throughout the process
US$ 20.34
US$ 23.00
US$ 24.30
US$ 20.22
US$ 28.21
US$ 28.26
US$ 24.39
US$ 21.41
US$ 24.01
US$ 25.06
US$ 29.40
US$ 20.30
US$ 26.43
